Articles citing this paper
Drug treatment clients' readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings
Carla Treloar and Martin Holt
32(3) pp.570 - 576
31 articles found in Crossref database.
General practitioner attitudes to prescribing hepatitis C antiviral therapy in a community setting
Lambert Stephen M.,
Page Andrew N.,
Wittmann Johannes,
Hayllar Jeremy S.,
Ferndale Clint W.,
Bain Tanya M., Macdonald Graeme A.
Australian Journal of Primary Health. 2011 17(3). p.282
The Role of Physicians’ Attitudes and the Provision of Hepatitis C Virus Treatment to People Who Inject Drugs
Myles Angelique
Open Medicine Journal. 2016 3(1). p.104
‘Makes you wanna do treatment’: Benefits of a hepatitis C specialist clinic to clients in Christchurch, New Zealand
Brener Loren,
Gray Rebecca,
Cama Elena J., Treloar Carla
Health & Social Care in the Community. 2013 21(2). p.216
Hepatitis C Infection and Treatment among Injecting Drug Users Attending General Practice: A Systematic Review and Meta-Analysis
Tandan Meera,
Dunlea Shane, Bury Gerard
International Journal of Environmental Research and Public Health. 2023 20(8). p.5569
The Lived Experience of Hepatitis C and its Treatment Among Injecting Drug Users: Qualitative Synthesis
Treloar Carla, Rhodes Tim
Qualitative Health Research. 2009 19(9). p.1321
Factors associated with HCV antiviral treatment uptake among participants of a community‐based HCV programme for marginalized patients
Charlebois A.,
Lee L.,
Cooper E.,
Mason K., Powis J.
Journal of Viral Hepatitis. 2012 19(12). p.836
Perceived Barriers to Hepatitis C Therapy for Patients Receiving Opioid Agonist Treatment
Zickmund Susan L.,
Campbell Scott A.,
Tirado Carlos F.,
Zook Carolyn L., Weinrieb Robert M
Journal of Addiction Medicine. 2012 6(3). p.233
Mapping the Barriers and Facilitators of HCV Treatment Initiation in Methadone Maintenance Therapy Patients: Implications for Intervention Development
Bass Sarah Bauerle,
Jessop Amy,
Maurer Laurie,
Gashat Muhamed,
Al Hajji Mohammed, Gutierrez Mercedes
Journal of Health Communication. 2018 23(1). p.117
Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore
Falade-Nwulia Oluwaseun,
Irvin Risha,
Merkow Alana,
Sulkowski Mark,
Niculescu Alexander,
Olsen Yngvild,
Stoller Kenneth,
Thomas David L.,
Latkin Carl, Mehta Shruti H.
Journal of Substance Abuse Treatment. 2019 100 p.45
Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection
Fusfeld Lauren,
Aggarwal Jyoti,
Dougher Carly,
Vera-Llonch Montserrat,
Bubb Stephen,
Donepudi Mrudula, Goss Thomas F
BMC Infectious Diseases. 2013 13(1).
Positive health beliefs and behaviours in the midst of difficult lives: Women who inject drugs
Olsen A.,
Banwell C.,
Dance P., Maher L.
International Journal of Drug Policy. 2012 23(4). p.312
Exploring patient characteristics and barriers to Hepatitis C treatment in patients on opioid substitution treatment attending a community based fibro-scanning clinic
Crowley Des,
Cullen Walter,
Laird Eamon,
Lambert John S.,
Mc Hugh Tina,
Murphy Carol, Van Hout Marie Claire
Journal of Translational Internal Medicine. 2017 5(2). p.112
Consideration of gender in diagnosis and management of blood-borne viruses: the case of hepatitis C
Olsen Anna,
Temple-Smith Meredith, Banwell Cathy
Australian Journal of Primary Health. 2013 19(2). p.124
Injecting practices in sexual partnerships: Hepatitis C transmission potentials in a ‘risk equivalence’ framework
Harris Magdalena, Rhodes Tim
Drug and Alcohol Dependence. 2013 132(3). p.617
Concurrent group treatment for hepatitis C: Implementation and outcomes in a methadone maintenance treatment program
Stein Melissa R.,
Soloway Irene J.,
Jefferson Karen S.,
Roose Robert J.,
Arnsten Julia H., Litwin Alain H.
Journal of Substance Abuse Treatment. 2012 43(4). p.424
Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs
Treloar Carla,
Hull Peter,
Bryant Joanne,
Hopwood Max,
Grebely Jason, Lavis Yvonna
Drug and Alcohol Dependence. 2011 116(1-3). p.52
Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting
Harris Magdalena,
Rhodes Tim, Martin Anthea
Social Science & Medicine. 2013 83 p.19
Review of patient-reported outcome measures in chronic hepatitis C
Kleinman Leah,
Mannix Sally,
Yuan Yong,
Kummer Shannon,
L’Italien Gilbert, Revicki Dennis
Health and Quality of Life Outcomes. 2012 10(1). p.92
‘Beyond the willing & the waiting’ — The role of peer-based approaches in hepatitis C diagnosis & treatment
Henderson Charles,
Madden Annie, Kelsall Jenny
International Journal of Drug Policy. 2017 50 p.111
Gazing into the Scarlet Crystal Ball: Social Work and Hepatitis C
Paylor I., Mack H.
British Journal of Social Work. 2010 40(7). p.2291
Hepatitis C and Social Work
Mack Heather, Paylor Ian
British Journal of Social Work. 2016 46(4). p.1115
Efficacy of Sofosbuvir plus Ribavirin in Treatment-Naive Patients with Genotype-1 and -3 HCV Infection: Results from a Russian Phase IIIb Study
Isakov Vasily,
Zhdanov Konstantin,
Kersey Kathryn,
Svarovskaia Evguenia,
Massetto Benedetta,
Zhu Yanni,
Knox Steven J,
Bakulin Igor, Chulanov Vladimir
Antiviral Therapy. 2016 21(8). p.671
HIV and hepatitis C virus-related misinformation may contribute to rising rates of infection and suboptimal clinical outcomes among persons with substance use
De La Hoz Alejandro,
Graves Kristin,
Bernstein Judith A., Assoumou Sabrina A.
AIDS Care. 2024 p.1
Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors
Harris Magdalena, Rhodes Tim
Harm Reduction Journal. 2013 10(1). p.7
A Descriptive Model of Patient Readiness, Motivators, and Hepatitis C Treatment Uptake among Australian Prisoners
Yap Lorraine,
Carruthers Susan,
Thompson Sandra,
Cheng Wendy,
Jones Jocelyn,
Simpson Paul,
Richards Alun,
Thein Hla-Hla,
Haber Paul,
Lloyd Andrew,
Butler Tony, Tucker Joseph David
PLoS ONE. 2014 9(2). p.e87564
Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals
Rich Zachary C.,
Chu Carissa,
Mao Jessica,
Zhou Kali,
Cai Weiping,
Ma Qingyan,
Volberding Paul, Tucker Joseph D.
BMC Public Health. 2016 16(1).
Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective
Fokuo J. Konadu,
Masson Carmen L.,
Anderson August,
Powell Jesse,
Bush Dylan,
Ricco Margaret,
Zevin Barry,
Ayala Claudia, Khalili Mandana
Hepatology Communications. 2020 4(5). p.646
Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support
Grebely Jason,
Knight Elizabeth,
Genoway Krista A.,
Viljoen Mark,
Khara Milan,
Elliott Doug,
Gallagher Lesley,
Storms Michelle,
Raffa Jesse D.,
DeVlaming Stanley,
Duncan Fiona, Conway Brian
European Journal of Gastroenterology & Hepatology. 2010 22(3). p.270
Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view
TRELOAR CARLA J., FRASER SUZANNE M.
Drug and Alcohol Review. 2009 28(4). p.436
Care and treatment of hepatitis C among Aboriginal people in New South Wales, Australia: implications for the implementation of new treatments
Treloar Carla,
Jackson Clair,
Gray Rebecca,
Newland Jamee,
Wilson Hannah,
Saunders Veronica,
Johnson Priscilla, Brener Loren
Ethnicity & Health. 2016 21(1). p.39
Is the severity of the Great Recession's aftershocks correlated with changes in access to the combined prevention environment among people who inject drugs?
Wise Akilah,
Kianian Behzad,
Chang Howard H.,
Linton Sabriya,
Wolfe Mary E.,
Smith Justin,
Tempalski Barbara,
Jarlais Don Des,
Ross Zev,
Semaan Salaam,
Wejnert Cyprian,
Broz Dita, Cooper Hannah L.F.
International Journal of Drug Policy. 2021 95 p.103264
